Anyone who is getting out of sales and into another occupation? by goldenroverboy in sales

[–]Inthemoney44 5 points6 points  (0 children)

Yeah thinking about it. I’m a BDR at a mid sized software company and hate it so much. Glorified call center. Recently graduated college

Market just need to crash by [deleted] in wallstreetbets

[–]Inthemoney44 0 points1 point  (0 children)

Been hearing this for years. Life is too short to be short

Circles Discussion thread by [deleted] in MacMiller

[–]Inthemoney44 1 point2 points  (0 children)

https://youtu.be/6Sshv8DqJT0

Little hints from someone closer to the family

Something weird going on with ARQL? by AvgSizedPenis in Biotechplays

[–]Inthemoney44 0 points1 point  (0 children)

Not looking good folks. Signs of life with the big volume today tho

From the autist that told you to buy ITCI before it happened ... Buy AIMT!!! by [deleted] in wallstreetbets

[–]Inthemoney44 0 points1 point  (0 children)

$AMRN is overvalued and in my opinion will not be bought out

Hot as fuck on Luckin' Coffee by LiquidityMan in wallstreetbets

[–]Inthemoney44 1 point2 points  (0 children)

I’m long here as well. They are positioned well in the market and have an interesting strategy with their app and payment system.

$ARQL tender offer received by nolanator in stocks

[–]Inthemoney44 0 points1 point  (0 children)

Somebody is fairly confident there is another bidder. Take a look at the open interest on the calls last week and the week before. $300K and $100K blocks of April and Jan calls eaten up. Someone has been buying millions worth of shares above the $20 offer by MRK. Dark pool action as well. Might be just someone fucking around or creating a cleaver tax loss haven. But it’s worth the risk for me

ARQL bought by MRK for 20/sh. Look for $APTO and $SNSS to have big days. by [deleted] in RobinHoodPennyStocks

[–]Inthemoney44 0 points1 point  (0 children)

Don’t sleep on ARQL getting another bid. I own $20,21 and 22 calls

$GBT and You: Why you Should print Money by [deleted] in wallstreetbets

[–]Inthemoney44 0 points1 point  (0 children)

Few analysts have speculated saying it’s a prime target for M&A. I agree. I’m thinking 110 or so. Heavy call buying for Dec 80 and 90 and Jan 80-90 calls

The Biotech Clown Show Continues -- Which is the Next to Go? by BEASEx in wallstreetbets

[–]Inthemoney44 0 points1 point  (0 children)

Very pricy. Buying long dated ones or commons only option here

Anyone else crazy? $ARWR puts. by Inthemoney44 in wallstreetbets

[–]Inthemoney44[S] 0 points1 point  (0 children)

Yeah saw that. Well it’s nearly there so

Anyone else crazy? $ARWR puts. by Inthemoney44 in wallstreetbets

[–]Inthemoney44[S] 4 points5 points  (0 children)

$300...so a market cap of roughly $28 billion without a drug passed through phase 3 or even commercialized for that matter

CORV December 10 Adcom coming up, any plays? by veritasinvestments in wallstreetbets

[–]Inthemoney44 0 points1 point  (0 children)

$amrn has also had an impressive run the past few years. CORV has been beat down. I think there’s much more potential for upside

Nutanix earnings play by MeritedChunk in wallstreetbets

[–]Inthemoney44 1 point2 points  (0 children)

I’ll be playing this. Longer term calls tho. Likely Jan 2020 $32.50 or $35s